¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"hemoglobin M disease"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
À̰ÍÀ» ¿øÇϼ̽À´Ï±î?
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
  • reported communicable disease
    ½Å°íµÈÀü¿°º´
  • respiratory disease
    È£Èí±âÁúȯ
  • reversible obstructive lung disease
    °¡¿ªÆó¼âÆóº´, °¡¿ªÆó¼âÆóÁúȯ
  • rheumatic disease
    ·ù¸¶Æ¼½ºº´
  • rheumatoid disease
    ·ù¸¶Æ¼½º¸ð¾çÁúȯ
  • rice disease
    ½Òº´, °¢±âº´
  • rickettsial disease
    ¸®ÄÉÂ÷º´
  • Ritter¡¯s disease
    ¸®Åͺ´
  • rolling disease
    ȸÀüº´
  • spinocerebellar disease
    ô¼ö¼Ò³úº´
  • spirochetal disease
    ½ºÇÇ·ÎÇ쟺´
  • sterility disease
    ºÒÀÓº´
  • Schilder disease
    ½Ç´õº´
  • storage disease
    ÃàÀûº´
  • systemic disease
    Àü½Åº´
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 14 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
  • tsutsugamushi disease
    ÂêÂê°¡¹«½Ãº´
  • tubulointerstitial disease
    ¿ä¼¼°ü»çÀÌÁúÁúȯ, ¿ä¼¼°ü°£Áúº´
  • upper respiratory disease
    »ó±âµµº´
  • uremic medullary cystic disease
    ¿äµ¶¼ÓÁú³¶º´
  • valvular heart disease
    ÆÇ¸·½ÉÀ庴
  • vascular disease
    Ç÷°üº´
  • venereal disease
    ¼ºº´
  • veno-occlusive disease
    Á¤¸ÆÆó¼âº´
  • viral disease
    ¹ÙÀÌ·¯½ºº´
  • wasting disease
    ¼Ò¸ðº´
  • white-spot disease
    ¹é»öÁ¡º´
  • law of prophylaxis for infectious disease
    Àü¿°º´¿¹¹æ¹ý
  • tracer disease method
    ÃßÀûÁúº´¹æ¹ý
  • venereal disease research laboratory test
    ¸Åµ¶Ç÷û°Ë»ç
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
  • acute febrile neutrophilic dermatosis = Sweet disease
    ±Þ¼º À¯¿­ È£Áß±¸¼º ÇǺÎÁõ
  • acute infectious disease
    ±Þ¼º °¨¿°Áúȯ
  • acute infectious disease =AID
    ±Þ¼º Àü¿°º´(¡­îîæøÜ»).
  • acute respiratory disease =ARD
    ±Þ¼º È£Èí±âº´(¡­û¼ýåÐïÜ»).
  • acute respiratory disease =ARD
    ±Þ¼º È£Èí±âº´(¡­û¼ýåÐïÜ»).
  • addisons disease
    ¾Öµð½¼º´<<ºÎ½Å±â´ÉºÎÀü>>
  • addisons disease
    ¾Öµð½¼º´(¡­Ü»)
  • adipose tissue disease
    Áö¹æÁ¶Á÷Áúȯ.
  • adjuvant disease
    ¾ÖÁÖ¹øÆ®º´.
  • adult disease
    ¼ºÀκ´(à÷ìÑÜ»).
  • african sleeping disease
    ¾ÆÇÁ¸®Ä« ¼ö¸éº´(¡­â²ØùÜ»)
  • air borne disease
    °ø±â¸Å°³Áúȯ.
  • air pilots disease
    ºñÇàÁ¶Á¾»çº´.
  • air space disease
    °ø±â °ø°£ Áúȯ
  • aircraft disease
    Ç×°øº´.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
  • complicating disease
    ÇÕº´Áõ(ùêܱñø).
  • compressed air disease
    ¾ÐÃà°ø±âº´, °í±â¾Ðº´.
  • congenital heart disease
    ¼±Ãµ¼º ½ÉÁúȯ(à»ô¸àõãýòðü´).
  • congenital heart disease
    ¼±Ãµ¼º ½ÉÁúȯ(¡­ãýòðü´)
  • connate disease
    ¼±Ãµº´(à»ô¸Ü»).
  • connective tissue disease
    °áÇÕÁ¶Á÷ Áúȯ(¡­òðü´)
  • connective tissue disease,mixed
    È¥ÇÕ¼º(ûèùêàõ)
  • constitutional disease
    üÁú¼º Áúȯ.
  • constrictive heart disease
    ±³Âø¼º ½ÉÁúȯ(¡­àõãýòðü´).
  • consumption disease
    ¼Ò¸ð¼º Áúȯ.
  • contagious disease
    Àü¿°º´
  • contagious disease
    (Á¢ÃË)Àü¿°º´(ïÈõºîîæøÜ»), (Á¢ÃË)°¨¿°Áõ(¡­Êïæøñø).
  • copper storage disease
    µ¿ÀúÀåÁúȯ(ÔÞîÍíúòðü´).
  • coris disease
    ÄÚ¸®º´(¡­Ü»)
  • coronary artery disease
    °ü(»ó)µ¿¸ÆÁúȯ(¡­òðü´).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 20
DILD diffuse infiltrative lung disease; diffuse interstitial lung disease
DPD Department of Public Dispensary; depression pure disease; desoxypyridoxine; diffuse pulmonary diseas...
ED early-decision [applicant]; early differentiation; ectodermal dysplasia; ectopic depolarization; eff...
GSD genetically significant dose; Gerstmann-Straussler disease; glutathione synthetase deficiency; glyco...
HLD hepatolenticular degeneration; herniated lumbar disk; Hippel-Lindau disease; hypersensitivity lung d...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 20
cGVHD Chronic graft versus host disease
cGVHD Chronic graft-vs.-host disease
CIBD Chronic inflammatory bowel disease
CLD Chronic liver disease
CNSLD Chronic non-specific lung disease
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • Weil's disease Ȳ´Þ ÃâÇ÷¼º ·¾Å佺ÇǶóÁõ.

    Weinrich et Emmerson

    ¼è¼¼¸ðÆí¸ðÃæ
  • Werlhof disease
    º£¸¦È£ÇÁ º´
    ÇǺο¡ ÃâÇ÷À» º¼ ¼ö ÀÖ´Â Àڹݺ´ÀÇ Çϳª·Î¼­ Ư¹ß¼º Ç÷¼ÒÆÇ °¨¼Ò¼º Àڹݺ´, ÃâÇ÷¼º Àڹݺ´À̶ó°íµµ ÇÑ´Ù. ÇǺγª Á¡¸·
  • wernicke's disease
    º£¸£´ÏÄɺ´
    µ¿ÀǾî=
  • whipple's disease Èí¼öºÎÀü ÁõÈıºÀ¸·Î ¼³»ç, Áö¹æ º¯Áõ, ÇǺλö¼Ò Ä§Âø, °üÀý¿°, °üÀýÅë, ¸²ÇÁÀý¿°, ÁßÃ߽Űæ°èÀå¾Ö°¡ Ư¡ÀÌ´Ù.

    Whipple's triad

    ÇÇÇþ¾ »ï¡ÈÄ
    ¿øÀο¡ °ü°è¾øÀÌ ¸ðµç ÀúÇ÷´çÁõÀÇ Æ¯Â¡À¸·Î 1
  • white finger disease
    ¹é¶øº´
    ¾ÐÃà°ø±â, ÇØ¸Ó, Àüµ¿ Åé µî ¼Õ¿¡ Áã°í Á¶ÀÛÇÏ´Â Áøµ¿°ø±¸ÀÇ Áøµ¿À¸·Î ¼ÕÀÇ µ¿¸ÆÀÌ Àå¾Ö¸¦ ¹Þ¾Æ °©Àڱ⠼հ¡¶ôÀÌ Ã¢¹éÇØÁö´Â º´. »çÁö ¸»´Ü, ƯÈ÷ ¼öÁöÀÇ Ç÷°üÀå¾Ö·Î ÁßÁõÀÏ ¶§´Â ȯºÎ°¡ ±«»ç¿¡ ºüÁö´Â Á÷¾÷º´À¸·Î ·¹À̳ë ÁõÈıºÀÇ ÇÑ º´ÇüÀ¸·Î °£ÁÖÇϰí ÀÖ´Ù. ¿øÀÎÀº Ç÷°ü ¿îµ¿ ½Å°æ Àå¾Ö·Î ÀÎÇÑ µ¿¸Æ ¼öÃà ¶§¹®¿¡ ÀϾ´Â Ç÷·ù Àå¾ÖÀÌ´Ù. Áõ¼¼´Â ¹ßÀÛÀûÀ¸·Î ÀϾ ¼Õ°¡¶ôÀÌ Ã¢¹éÇØÁö¸ç, ÅëÁõ°ú Àú¸®´Â °¨ÀÌ ÀÖ°í, ÀÌ¾î º¸¶ó»öÀ¸·Î º¯Çß´Ù°¡ ºÓ¾îÁö¸é¼­ ȸº¹µÇ¸ç, ÀÌ »çÀÌ´Â ¼öºÐ ³»Áö ¼ö ½Ê ºÐÀ̰í Ãß¿ï ¶§ ¸¹´Ù. Ä¡·á´Â Ç÷°üÈ®ÀåÁ¦¸¦ »ç¿ëÇÏ°í ¼ÕÀ» Â÷Áö ¾Ê°Ô º¸¿Â¿¡ ÁÖÀÇÇϸç, °ø±¸ »ç¿ëÀº ÀÏÁ¤ ±â°£ »ï°¡´Â °ÍÀÌ ÁÁ´Ù.
  • woolsorters disease
    ¾ç¸ð¾÷ÀÚº´
    ¾ç¸ð¸¦ Ãë±ÞÇÏ´Â »ç¶÷¿¡¼­ º¼ ¼ö ÀÖ´Â ÆóÀÇ ÅºÀú·Î, B. anthrax¸¦ ÈíÀÔÇÔÀ¸·Î½á ÀϾ´Ù.
  • Zahorsky's disease
    ÀÚÈ£¸£½ºÅ° º´
    À¯¾Æ¿¡¼­ º¼ ¼ö ÀÖ´Â µ¹¹ß¼º ¹ßÁø.
  • Ziehen-Oppengeim disease
    Á¦¿£-¿ÀÆæÇÏÀÓº´
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
glycogen storage disease type VIII <disease> An x-linked recessive hepatic glycogen storage disease resulting from lack of expression of phosphorylase-b-kinase activity. Symptoms are relatively mild; hepatomegaly, increased liver glycogen, and decreased leukocyte phosphorylase are present. Liver shrinkage occurs in response to glucagon.
Inheritance: X-linked recessive
(12 Dec 1998)
von Economo's disease A unique encephalitis, presumably viral in origin, which followed the influenza pandemic of 1914-1918. Symptoms included ophthalmoplegia and marked somnolence, and in many survivors, the delayed development of Parkinson's disease; the basis for postencephalitic Parkinsonism.
Synonym: encephalitis lethargica, polioencephalitis infectiva.
(05 Mar 2000)
Von Gierke's disease <disease> A congenital disease caused by a metabolic error in which the body deposits an abnormally high amount of glycogen in the kidneys and liver, the disease produces symptoms such as hypoglycaemia (low blood sugar) and hyperlipaemia (an excess of lipid molecules in the blood, which can lead to problems such as clogged arteries and heart attacks).
(09 Oct 1997)
von hippel-lindau disease <disease> A congenital disease characterised by the development of blood vesse ltumours in the retina of the eye and in the brain, lesions and cysts canalso develop in the spina lcord, pancreas, kidneys, and other organs.
(09 Oct 1997)
pelvic imflammatory disease <disease> The inflammation of any of the female pelvic organs, usually due to infection from a sexually transmitted disease. PID can result in sterility if left untreated.
(09 Oct 1997)
pelvic inflammatory disease <disease> An inflammatory process that results from other pelvic diseases, may result from gonorrhoea, chlamydia, ovarian cystic disease or postpartum infections.
(27 Sep 1997)
von Meyenburg's disease A degenerative disease of cartilage producing a bizarre form of arthritis, with collapse of the ears, the cartilaginous portion of the nose, and the tracheobronchial tree; death may occur from chronic infection or suffocation because of loss of stability in the tracheobronchial tree of autosomal origin.
Synonym: chronic atrophic polychondritis, generalised chondromalacia, Meyenburg's disease, Meyenburg-Altherr-Uehlinger syndrome, relapsing perichondritis, systemic chondromalacia, von Meyenburg's disease.
(05 Mar 2000)
von Recklinghausen disease type 1 neurofibromatosis
von Recklinghausen's disease <disease> A rare genetic disorder which affects the cell growth of nerve tissue. Individuals have multiple cutaneous and subcutaneous tumours which appear in late childhood.
Clinical features include medium-brown, flat discolourations to the skin, known as cafe-au-lait spots.
Secondary hypertension may develop from renal artery stenosis, pheochromocytoma or coarctation of the aorta.
Inheritance: autosomal dominant.
(04 Nov 1997)
Von Willebrand disease <disease, haematology> A hereditary platelet disorder caused by defective or deficient Von Willebrand factor, a protein involved in normal blood clotting, that reduces adhesion to collagen but not aggregation. Both bleeding time and coagulation are increased. Factor VIII levels are secondarily reduced.
Symptoms include nosebleeds, bleeding gums, heavy menstrual bleeding, bruising and skin rashes.
Inheritance: autosomal dominant.
(30 Sep 1997)
Von Willebrand's disease <disease> This congenital disease, which is caused a deficiency of a blood factor that promotes platelet adhesion, is characterised by prolonged bleeding and poor blood coagulation.
(09 Oct 1997)
Voorhoeve's disease Linear striations seen radiographically in the metaphyses of long bones and also flat bones; it may be a variant of osteopoikilosis.
Synonym: Voorhoeve's disease.
(05 Mar 2000)
Meige's disease Autosomal dominant lymphedema with onset at about the age of puberty.
(05 Mar 2000)
cerebrovascular disease <cardiology, pathology> A general term which encompasses a variety of diseases which affect (via the occlusive effects of atherosclerosis) the arteries which supply the brain.
See: stroke.
(12 Jan 1998)
retinal disease <ophthalmology> A general term which describes any retinal changes (haemorrhages or exudates) that can affect vision (for example diabetic retinopathy, hypertensive retinopathy).
(27 Sep 1997)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 20
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 20
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 20
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 20
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 20
ÅëÇÕ°Ë»ö ¿Ï·á